Year: 2023

340B Lobbying Still on Track for Record Year

November 2, 2023 Rich Daly, Editor in Chief Views

Darbin Wofford, a health policy advisor at Third Way, said his organization is urging Congressional Democrats to adopt 340B program reforms.

Lobbying on 340B issues in 2023 remains on track for a record-breaking year, according to recently released congressional lobbying reports. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

New York State Asks Court to Dismiss Challenge to Medicaid Drug Benefit Shift

November 2, 2023 Tom Mirga, Editor at Large Views

The New York State Department of Health asked a state trial court to dismiss two providers' challenge to a Medicaid drug benefit shift.

The New York State Department of Health recently told a state trial court in Manhattan that two community health centers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Program May Lead to Lower Charity Care, Says Drug Industry-Backed AIDS Group

November 2, 2023 William Newton, Associate Editor/Senior Writer Views

Brandon Macsata, CEO of ADAP Advocacy, said the group plans to publish data from its ongoing study on the 340B program later this year.

Enrollment in the 340B program was linked to diminished spending on charity care, according to preliminary findings from an ongoing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Expert Tip from RxStrategies

November 2, 2023 Sponsored Content Views

Sandoz Is 28th Drugmaker to Adopt 340B Contract Pharmacy Restrictions

November 1, 2023 Tom Mirga, Editor at Large Views

Drugmaker Sandoz, a Novartis spin-off, became the 28th pharmaceutical company to implement 340B contract pharmacy restrictions.

Generic and biosimilar drugmaker Sandoz today became the 28th pharmaceutical company to place conditions on 340B pricing involving drug shipments [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

October 31, 2023 William Newton, Associate Editor/Senior Writer Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Hospital Registration Waiver Withdrawal Could Draw Legal Challenge

October 31, 2023 Tom Mirga, Editor at Large Views

Dept. of Health and Human Services building and signage

Hospital advocates said HRSA's recent decision to end a 340B program waiver for hospitals could draw legal challenges.

The recent end of a 340B program waiver for hospitals is wrong, hurts hospitals and their patients, and is bound [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arkansas Defends Enforcement of 340B Contract Pharmacy Law in Drugmaker Suit

October 31, 2023 William Newton, Associate Editor/Senior Writer Views

Arkansas Insurance Department office sign

The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.

Federal courts should allow enforcement of Arkansas’ 340B contract pharmacy law to continue unimpeded, an attorney representing Arkansas told a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B…or not to B…?

October 31, 2023 Sponsored Content Views

The current 340B climate

340B Hospitals’ Community Benefit Surges in 2020, Says Hospital-Backed Report

October 31, 2023 Rich Daly, Editor in Chief Views

The American Hospital Association published a study that found 340B hospitals' community benefit increased significantly in 2020.

The community benefits provided by 340B hospitals surged by $16.5 billion, or 24%, in the latest year analyzed by a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Year: 2023

340B Lobbying Still on Track for Record Year

Please Login or Become a Paid Subscriber to View this Content

If you are already a

New York State Asks Court to Dismiss Challenge to Medicaid Drug Benefit Shift

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Program May Lead to Lower Charity Care, Says Drug Industry-Backed AIDS Group

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Expert Tip from RxStrategies

News Alert

Sandoz Is 28th Drugmaker to Adopt 340B Contract Pharmacy Restrictions

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Hospital Registration Waiver Withdrawal Could Draw Legal Challenge

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Arkansas Defends Enforcement of 340B Contract Pharmacy Law in Drugmaker Suit

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B…or not to B…?

340B Hospitals’ Community Benefit Surges in 2020, Says Hospital-Backed Report

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live